FDA

News and Updates by the Food and Drugs Administration (FDA)

Bioretec Enters US Market with New Sales Partnership for RemeOs Trauma Screw Distribution

Bioretec Ltd, a trailblazing organization committed to innovating biodegradable orthopedic solutions, is propelling forward with the next stage of bringing its cutting-edge RemeOs Trauma Products to the US marketplace. Building on an earlier logistics agreement with GlobalMed Logistix, Bioretec is […]

Bioretec Enters US Market with New Sales Partnership for RemeOs Trauma Screw Distribution Read More »

Leads Biolabs Secures US FDA Orphan Drug Status for LBL-024 Antibody Targeting Neuroendocrine Cancer

Nanjing-based Leads Biolabs Co., Ltd., a clinical-stage biotechnology firm established by a team of experienced antibody drug developers trained in the United States, has announced a major advancement in the development of its proprietary bispecific antibody, LBL-024. The United States

Leads Biolabs Secures US FDA Orphan Drug Status for LBL-024 Antibody Targeting Neuroendocrine Cancer Read More »

Zai Lab and Pfizer Collaborate to Introduce Innovative Antibacterial Drug Xacduro in Mainland China

Zai Lab and Pfizer have entered into a strategic partnership focusing on the cutting-edge antibacterial medication Xacduro (sulbactam-durlobactam) for the market in mainland China. This initiative grants Pfizer’s partner entities exclusive rights to undertake various commercialization tasks for Xacduro within

Zai Lab and Pfizer Collaborate to Introduce Innovative Antibacterial Drug Xacduro in Mainland China Read More »

Zenyaku Kogyo Secures Japanese Approval for Rituxan to Address Chronic ITP in Pediatric Patients

The pharmaceutical firms Zenyaku Kogyo Co., Ltd. and Chugai Pharmaceutical Co., Ltd. have announced that Zenyaku has successfully secured regulatory authorization from Japan’s Ministry of Health, Labour and Welfare (MHLW) to expand the use of the anti-CD20 monoclonal antibody, Rituxan,

Zenyaku Kogyo Secures Japanese Approval for Rituxan to Address Chronic ITP in Pediatric Patients Read More »

Biotechnology to Unlock New Pathways in Precision Bio-Therapeutics & Eco-Friendly Chemicals

The central government is prioritizing the dual focus of the biotechnology sector towards embracing digital and green technologies. This approach aims to facilitate sustainable advancement and promote growth in a low-carbon economy. With biotechnology’s industrialization, there’s a surge of innovation,

Biotechnology to Unlock New Pathways in Precision Bio-Therapeutics & Eco-Friendly Chemicals Read More »

Tamil Nadu Prepares to Celebrate Pharmacy Week on November 29 with TN IPA & Dr MGR Medical University Collaboration

The annual observance of the 63rd National Pharmacy Week in Tamil Nadu will see a joint coordination effort by the state’s branch of the Indian Pharmaceutical Association (TN IPA) and the esteemed Tamil Nadu Dr MGR Medical University. This year,

Tamil Nadu Prepares to Celebrate Pharmacy Week on November 29 with TN IPA & Dr MGR Medical University Collaboration Read More »